Jae Jung, PhD has been appointed chair of Lerner Research Institute's Department of Cancer Biology where he will lead the department’s work in understanding the biological underpinnings of cancer ranging from genetic and molecular pathways to disease manifestation.
He will also serve as director of the Cleveland Clinic's new Center for Global and Emerging Pathogens Research which will focus on public health threats ranging from the Zika virus to SARS-CoV-2.
Dr. Jung is a member of the Case Comprehensive Cancer Center's Molecular Oncology Program.